Last reviewed · How we verify
Hydroxychloroquine Sulfate Tablets
Hydroxychloroquine Sulfate Tablets is a Small molecule drug developed by Xingchen Peng. It is currently FDA-approved. Also known as: Fenle, Plaquenil, HCQ.
Hydroxychloroquine Sulfate Tablets are a small molecule inhibitor of Ferriprotoporphyrin IX, classified as an INHIBITOR drug class. They have been studied in clinical trials for conditions such as COVID-19, Coronavirus Infection, and Acute Respiratory Infection, with various dosing regimens including daily and weekly dosing.
At a glance
| Generic name | Hydroxychloroquine Sulfate Tablets |
|---|---|
| Also known as | Fenle, Plaquenil, HCQ |
| Sponsor | Xingchen Peng |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Immunomodulatory Treatment of Interstitial Lung Disease Associated With Surfactant Related Gene Variants (PHASE2)
- Study of Hydroxychloroquine in Patients With X-linked Alport Syndrome in China (CHXLAS) (PHASE2)
- HCQ in Resectable Localized Prostate Cancer (EARLY_PHASE1)
- Autophagy Maintenance (AUTOMAIN) (PHASE2)
- Acute Rhabdomyolysis and Muscle Pain Associated With Mutations in the LPIN1 Gene - A Retrospective Study Describing the Safety and Efficacy of Hydroxychloroquine Sulfate Given on a Compassionate Basis to Patients Suffering From Lipin-1 Deficiency
- Effect of HCQ Combined With LT4 on LBR in Euthyroid Women With URPL and TPO-Ab (NA)
- Hydroxychloroquine as a Steroid-sparing Agent in Extrapulmonary Sarcoidosis (PHASE4)
- A Study of ABC294640 Alone and in Combination With HCQ Sulfate in the Treatment of Advanced Cholangiocarcinoma (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Hydroxychloroquine Sulfate Tablets CI brief — competitive landscape report
- Hydroxychloroquine Sulfate Tablets updates RSS · CI watch RSS
- Xingchen Peng portfolio CI
Frequently asked questions about Hydroxychloroquine Sulfate Tablets
What is Hydroxychloroquine Sulfate Tablets?
Who makes Hydroxychloroquine Sulfate Tablets?
Is Hydroxychloroquine Sulfate Tablets also known as anything else?
What development phase is Hydroxychloroquine Sulfate Tablets in?
Related
- Manufacturer: Xingchen Peng — full pipeline
- Also known as: Fenle, Plaquenil, HCQ
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing